BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bamaga AK, Alghamdi F, Alshaikh N, Altwaijri W, Bashiri FA, Hundallah K, Abukhaled M, Muthaffar OY, Al-Mehmadi S, Jamaly TA, Al-Muhaizea MA, Al-Saman A. Consensus Statement on the Management of Duchenne Muscular Dystrophy in Saudi Arabia During the Coronavirus Disease 2019 Pandemic. Front Pediatr 2021;9:629549. [PMID: 33681102 DOI: 10.3389/fped.2021.629549] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Elbashir H, Fathalla W, Mundada V, Iqbal M, Al Tawari AA, Chandratre S, Bastaki L, Romany I, Ismayl O, Abou Tayoun A. Gene Therapy for Duchenne Muscular Dystrophy: Unlocking the Opportunities in Countries in the Middle East and Beyond. JND 2022. [DOI: 10.3233/jnd-221528] [Reference Citation Analysis]
2 Kumar M, Digala L, Govindarajan R. COVID-19 in a Patient With Duchenne Muscular Dystrophy. J Clin Neuromuscul Dis 2022;23:231-2. [PMID: 35608650 DOI: 10.1097/CND.0000000000000394] [Reference Citation Analysis]
3 Wasilewska E, Sobierajska-Rek A, Śledzińska K, Małgorzewicz S, Jassem E, Wierzba J. Morbidity, Clinical Course and Vaccination against SARS-CoV-2 Virus in Patients with Duchenne Muscular Dystrophy: A Patient Reported Survey. Int J Environ Res Public Health 2021;19:406. [PMID: 35010666 DOI: 10.3390/ijerph19010406] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Leone E, Eddison N, Healy A, Royse C, Chockalingam N. Exploration of implementation, financial and technical considerations within allied health professional (AHP) telehealth consultation guidance: a scoping review including UK AHP professional bodies' guidance. BMJ Open 2021;11:e055823. [PMID: 34969656 DOI: 10.1136/bmjopen-2021-055823] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]